Fortis Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Fortis Capital Advisors's MRK Position: Q2 2026 in Review
Fortis Capital Advisors increased its Merck (MRK) stake by 37% in Q2 2026, buying an estimated $158K and bringing the position to 5,018 shares worth $645K. The position accounts for 0.07% of the portfolio, ranked #217.
Fortis Capital Advisors first reported a position in MRK in Q4 2022 and has held it in 7 quarters since. 2,083 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Fortis Capital Advisors held 5,018 shares of Merck worth $645K as of Q2 2026.
- Fortis Capital Advisors bought 1,350 Merck shares in Q2 2026, an estimated $158K.
- Merck made up 0.07% of Fortis Capital Advisors's portfolio in Q2 2026, its #217 holding.
- Fortis Capital Advisors first reported a position in Merck in Q4 2022 and has held it in 7 quarters since.
- 2,083 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.